Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Feb;34(2):196–201. doi: 10.1128/aac.34.2.196

Effects of antifungal agents on the function of human neutrophils in vitro.

E Roilides 1, T J Walsh 1, M Rubin 1, D Venzon 1, P A Pizzo 1
PMCID: PMC171555  PMID: 2158275

Abstract

Polymorphonuclear leukocytes (PMNs) are an important component of the host defense against fungi. We investigated the influence of five antifungal agents on PMN function and compared them with amphotericin B (AmB). The in vitro effects of AmB, flucytosine, ketoconazole, fluconazole, Sch-39304, and cilofungin (LY121019) on chemotaxis, phagocytosis, oxidative metabolism of PMN as reflected by superoxide anion (O2-) generation, and intracellular killing of Candida albicans blastoconidia were examined. With regard to chemotaxis in response to N-formylmethionyl-leucyl-phenylalanine, as measured by the multiwell chamber method, AmB induced a marked decrease (greater than or equal to 5 micrograms/ml), whereas ketoconazole at 5 micrograms/ml enhance it. Phagocytosis was significantly decreased after pretreatment of PMNs with AmB and Sch-39304 (greater than 5 and 1 to 10 micrograms/ml, respectively). O2- production after stimulation of PMNs with N-formylmethionyl-leucyl-phenyl-alanine was significantly decreased by AmB (greater than 5 micrograms/ml) and enhanced by Sch-39304 (1 to 5 micrograms/ml). In contrast, intracellular killing, as tested by methylene blue staining, was enhanced by ketoconazole (5 micrograms/ml) and Sch-39304 (1 to 5 micrograms/ml). Flucytosine, fluconazole, and cilofungin did not affect PMN function at therapeutic concentrations. The results of this comprehensive study indicate that AmB, flucytosine, cilofungin, and the newer azoles, at safely achievable concentrations, generally do not suppress PMN function at therapeutic enhance selective functions.

Full text

PDF
196

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abruzzo G. K., Fromtling R. A., Turnbull T. A., Giltinan D. M. Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells. J Antimicrob Chemother. 1987 Jul;20(1):61–68. doi: 10.1093/jac/20.1.61. [DOI] [PubMed] [Google Scholar]
  2. Abruzzo G. K., Giltinan D. M., Capizzi T. P., Fromtling R. A. Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells. Antimicrob Agents Chemother. 1986 Apr;29(4):602–607. doi: 10.1128/aac.29.4.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bistoni F., Vecchiarelli A., Mazzolla R., Puccetti P., Marconi P., Garaci E. Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans. Antimicrob Agents Chemother. 1985 Apr;27(4):625–631. doi: 10.1128/aac.27.4.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Björkstén B., Ray C., Quie P. G. Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B. Infect Immun. 1976 Jul;14(1):315–317. doi: 10.1128/iai.14.1.315-317.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. Chan C. K., Balish E. Inhibition of granulocyte phagocytosis of Candida albicans by amphotericin B. Can J Microbiol. 1978 Apr;24(4):363–364. doi: 10.1139/m78-061. [DOI] [PubMed] [Google Scholar]
  7. Davies R. R., Zaini F. Antifungal drugs affecting the chemotaxis of polymorphonuclear neutrophils. Sabouraudia. 1985 Apr;23(2):119–123. doi: 10.1080/00362178585380191. [DOI] [PubMed] [Google Scholar]
  8. Denning T. J., Davies R. R. Candida albicans and the chemotaxis of polymorphonuclear neutrophils. Sabouraudia. 1973 Nov;11(3):210–221. [PubMed] [Google Scholar]
  9. Falk W., Goodwin R. H., Jr, Leonard E. J. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods. 1980;33(3):239–247. doi: 10.1016/0022-1759(80)90211-2. [DOI] [PubMed] [Google Scholar]
  10. Farkas B., Dobozy A. The effect of ketoconazole on the phagocytosis and intracellular killing of Candida albicans by polymorphonuclear granulocytes. Mykosen. 1983 Jan;26(1):22–26. doi: 10.1111/j.1439-0507.1983.tb03932.x. [DOI] [PubMed] [Google Scholar]
  11. Gordee R. S., Zeckner D. J., Ellis L. F., Thakkar A. L., Howard L. C. In vitro and in vivo anti-Candida activity and toxicology of LY121019. J Antibiot (Tokyo) 1984 Sep;37(9):1054–1065. doi: 10.7164/antibiotics.37.1054. [DOI] [PubMed] [Google Scholar]
  12. Johnson E. M., Warnock D. W., Richardson M. D., Douglas C. J. In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils. J Antimicrob Chemother. 1986 Jul;18(1):83–91. doi: 10.1093/jac/18.1.83. [DOI] [PubMed] [Google Scholar]
  13. Le Moli S., Seminara R., D'Amelio R., Pontesilli O., Nisini R. In vitro effect of ketoconazole on human neutrophil chemotaxis and Candida albicans killing. Boll Ist Sieroter Milan. 1983;62(6):531–534. [PubMed] [Google Scholar]
  14. Lehrer R. I., Cline M. J. Interaction of Candida albicans with human leukocytes and serum. J Bacteriol. 1969 Jun;98(3):996–1004. doi: 10.1128/jb.98.3.996-1004.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lingaas E., Midtvedt T. Dissociated effect of amphotericin B and desoxycholate on phagocytosis of Escherichia coli by human polymorphonuclear neutrophils. Drugs Exp Clin Res. 1985;11(11):747–754. [PubMed] [Google Scholar]
  16. Marmer D. J., Fields B. T., Jr, France G. L., Steele R. W. Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function. Antimicrob Agents Chemother. 1981 Nov;20(5):660–665. doi: 10.1128/aac.20.5.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rowan-Kelly B., Ferrante A., Thong Y. H. Modification of polymorphonuclear leucocyte function by imidazoles. Int J Immunopharmacol. 1984;6(4):389–393. doi: 10.1016/0192-0561(84)90059-6. [DOI] [PubMed] [Google Scholar]
  18. Saag M. S., Dismukes W. E. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother. 1988 Jan;32(1):1–8. doi: 10.1128/aac.32.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Senior D. S., Shaw J. T. In vitro effects of fluconazole (UK-49,858) and ketoconazole on mouse lymphocyte proliferation and on Candida blastospore destruction by human polymorphonuclear leukocytes. Int J Immunopharmacol. 1988;10(2):169–173. doi: 10.1016/0192-0561(88)90092-6. [DOI] [PubMed] [Google Scholar]
  20. Supapidhayakul S. R., Kizlaitis L. R., Andersen B. R. Stimulation of human and canine neutrophil metabolism by amphotericin B. Antimicrob Agents Chemother. 1981 Feb;19(2):284–289. doi: 10.1128/aac.19.2.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tukey J. W., Ciminera J. L., Heyse J. F. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics. 1985 Mar;41(1):295–301. [PubMed] [Google Scholar]
  22. Walsh T. J., Pizzo A. Treatment of systemic fungal infections: recent progress and current problems. Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):460–475. doi: 10.1007/BF01962595. [DOI] [PubMed] [Google Scholar]
  23. Yasui K., Masuda M., Matsuoka T., Yamazaki M., Komiyama A., Akabane T., Murata K. Miconazole and amphotericin B alter polymorphonuclear leukocyte functions and membrane fluidity in similar fashions. Antimicrob Agents Chemother. 1988 Dec;32(12):1864–1868. doi: 10.1128/aac.32.12.1864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yousif M. A., Hay R. J. Leucocyte chemotaxis to mycetoma agents--the effect of the antifungal drugs griseofulvin and ketoconazole. Trans R Soc Trop Med Hyg. 1987;81(2):319–321. doi: 10.1016/0035-9203(87)90252-5. [DOI] [PubMed] [Google Scholar]
  25. de Brabander M., Aerts F., van Cutsem J., van den Bossche H., Borgers M. The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. Sabouraudia. 1980 Sep;18(3):197–210. doi: 10.1080/00362178085380351. [DOI] [PubMed] [Google Scholar]
  26. van Rensburg C. E., Anderson R., Jooné G., van der Merwe M. F., Eftychis H. A. The effects of ketoconazole on cellular and humoral immune functions. J Antimicrob Chemother. 1983 Jan;11(1):49–55. doi: 10.1093/jac/11.1.49. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES